Role of STAT3 in lung cancer
- PMID: 26413424
- PMCID: PMC4580090
- DOI: 10.1080/21623996.2014.999503
Role of STAT3 in lung cancer
Abstract
Lung cancer remains a challenging disease. It is responsible for the high cancer mortality rates in the US and worldwide. Elucidation of the molecular mechanisms operative in lung cancer is an important first step in developing effective therapies. Accumulating evidence over the last 2 decades suggests a critical role for Signal Transducer and Activator of Transcription 3 (STAT3) as a point of convergence for various signaling pathways that are dysregulated in the disease. In this review, we discuss possible molecular mechanisms involving STAT3 in lung tumorigenesis based on recent literature. We consider possible roles of STAT3 in cancer cell proliferation and survival, in the tumor immune environment, and in epigenetic regulation and interaction of STAT3 with other transcription factors. We also discuss the potential role of STAT3 in tumor suppression, which complicates strategies of targeting STAT3 in cancer therapy.
Keywords: Non-canonical; U-STAT; immune evasion; miRNA; stem cell; tumor suppressor.
Figures

References
-
- World Health Organization Cancer. fact sheet no 297. US N Inst Health Nat Cancer Inst SEER Cancer Statistics Rev, 1975-2010, 2013.
-
- American Cancer Society Cancer facts and figures. 2014.
-
- Centers for Disease Control and Prevention National Center for Health Statistics. CDC WONDER On-line database, compiled from compressed mortality file 1999-2010 series 20 No. 2P, 2013.
-
- Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH, Eastern cooperative oncology G. comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. New Eng J Med 2002; 346:92-8; PMID:11784875; http://dx.doi.org/10.1056/NEJMoa011954 - DOI - PubMed
-
- Milosavljevic N, Duranton C, Djerbi N, Puech PH, Gounon P, Lagadic-Gossmann D, Dimanche-Boitrel MT, Rauch C, Tauc M, Counillon L, et al. . Nongenomic effects of cisplatin: acute inhibition of mechanosensitive transporters and channels without actin remodeling. Cancer Res 2010; 70:7514-22; PMID:20841472; http://dx.doi.org/10.1158/0008-5472.CAN-10-1253 - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous